Introduction
============

The prevalence of diabetes has been growing worldwide for the last few decades \[[@ref1]\], and it has become one of the four priority noncommunicable diseases targeted by world leaders, together with cardiovascular disease, cancer, and chronic respiratory disease \[[@ref1]\]. All types of diabetes can lead to complications, reduce the quality of life, and increase the risk of premature death \[[@ref1],[@ref2]\]. To support clinical practice, health authorities recommend educating diabetic patients and their families and initiating prevention measures aimed at improving self-management and promoting a positive behavior change, thereby reducing the risk of complications \[[@ref1]-[@ref7]\].

The use of social media has increased dramatically in the recent years \[[@ref8]\], and social media channels could be effective in supporting clinical practice and delivering education to improve self-management and to promote a positive behavior change among people affected with chronic diseases \[[@ref9]\]. However, it is not well known whether the use of these channels in interventions can help improve diabetic patients' outcomes, and the evidence of using social media in interventions for people with diabetes needs to be updated.

Evidence on positive effects of social media interventions on health behavior-related outcomes (ie, weight loss and physical activity) exists in 2 meta-analyses focusing on several health conditions \[[@ref10],[@ref11]\]. However, 2 other meta-analyses have reported mixed results regarding the use of social media in health interventions \[[@ref12],[@ref13]\]. Furthermore, a third meta-analysis concluded that using social media did not contribute to reducing risk factors in patients with noncommunicable diseases \[[@ref14]\].

Norway is one of the most connected countries in the world, and most of the Norwegian population uses social media \[[@ref15],[@ref16]\]. Due to its ubiquity, a health promotion intervention using social media, aimed at people affected by diabetes and their relatives, is now being initiated by our research team \[[@ref17]\]. An updated status on the evidence that exists regarding the use and usefulness of social media in diabetes is essential. Hence, the objective of this paper was to review and describe the current evidence on the use of social media in interventions targeting people with diabetes.

Methods
=======

A Rapid Review
--------------

We performed a rapid review to quickly capture the current evidence on the use of social media in interventions on diabetes. We had two research questions: (1) Is there evidence on the use of social media in interventions aimed at improving, maintaining, or promoting health among people affected with diabetes? and (2) What are the reported outcomes, for example, the effects on clinical parameters, effects on behavior, or other effects?

The rapid review method was chosen as it typically provides similar conclusions as systematic reviews, and it allows to quickly and efficiently access the current evidence on the topic \[[@ref18]-[@ref21]\]. In this rapid review, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) \[[@ref22]\] and the MeaSurement Tool to Assess systematic Reviews (AMSTAR) \[[@ref23],[@ref24]\] guidelines. This review has been registered in PROSPERO (registration number: CRD42018088206).

Search Strategy
---------------

To answer the research questions, we performed an electronic search on February 13, 2018. It covered published studies comprising the terms "Social media," "Social networking," "Facebook," "Twitter," or "YouTube" in combination with the term "Diabetes" included in the title or abstract and indexed in the following databases: PubMed (Medical Subject Heading terms and text word), Scopus, EMBASE, and the Cochrane Library. The search strategy was limited to studies published in English. The full search strategy is summarized in [Multimedia Appendix 1](#app1){ref-type="supplementary-material"}.

Inclusion and Exclusion Criteria
--------------------------------

Publications were included in the review if they (1) focused on diabetes or involved participants affected by diabetes; (2) described interventions aimed at improving, maintaining, or promoting health; (3) reported results from the intervention; and (4) used social media in the intervention. Both primary studies and reviews were considered to be of interest and were, therefore, included in this review. Papers that did not meet all four criteria were excluded from the review.

Eligibility and Data Extraction
-------------------------------

All references captured by the search engine were uploaded to EndNote X7 (Clarivate Analytics; Philadelphia, PA, USA). Duplicates were identified and removed. To assess the eligibility of the papers, two passes were done. In the first pass, all titles and abstracts were examined by one reviewer (EG). In the second pass, the full text of the studies selected on the first pass was extracted and carefully analyzed to confirm their eligibility. When it was unclear whether the studies should be included, they were discussed and agreed with a second reviewer (EÅ). The agreed upon studies were included in the quality assessment. A single reviewer (EG) extracted the data from the included studies. The following data were extracted: interventions (duration and participants), social media use (channels, use as main tool for the intervention or as supporting tool), and outcomes (effects on clinical parameters, on behavior, or other effects).

Quality Evidence Assessment and Risk of Bias
--------------------------------------------

The quality of evidence and risk of bias of the studies included in this review were classified by one reviewer (EG). The quality of evidence of primary studies was assessed following the Grading of Recommendations Assessment, Development and Evaluation guidelines \[[@ref25]\]. A second reviewer (RW) verified the assigned quality of a random sample of primary studies. The risk of systematic bias was assessed by drawing on the AMSTAR criteria \[[@ref19],[@ref23],[@ref24]\].

Results
=======

Sample
------

A total of 1383 publications were identified, and after removing duplicates, 676 titles and abstracts were screened. The full search strategy and its results are summarized in [Multimedia Appendix 1](#app1){ref-type="supplementary-material"}. The list of all potentially relevant studies that were read in full-text form but were excluded from the review can be found in [Multimedia Appendix 2](#app2){ref-type="supplementary-material"}. Of these publications, 35 met the inclusion criteria \[[@ref26]-[@ref60]\]; of them, 32 were primary studies \[[@ref26]-[@ref32],[@ref34]-[@ref38],[@ref40]-[@ref59]\] and 3 were systematic reviews \[[@ref33],[@ref39],[@ref60]\] ([Figure 1](#figure1){ref-type="fig"}).

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart of the selection procedure.](jmir_v20i8e10303_fig1){#figure1}

Quality of The Evidence and Risk of Bias Assessment
---------------------------------------------------

Only 1 of the 35 included studies was considered to be of high quality \[[@ref31]\]; 19 studies were considered to be of moderate quality: the 3 systematic reviews \[[@ref33],[@ref39],[@ref60],[@ref61]\] ([Multimedia Appendix 3](#app3){ref-type="supplementary-material"}), all 15 randomized controlled trials (RCTs) \[[@ref26]-[@ref30],[@ref32],[@ref34],[@ref35],[@ref42],[@ref44],[@ref45],[@ref48],[@ref54],[@ref55],[@ref58]\], and 1 nonrandomized intervention \[[@ref40]\]. The remaining 15 nonrandomized studies were weighted as being of low or very low quality, and therefore, they were removed from the narrative synthesis (these studies are listed in [Multimedia Appendix 4](#app4){ref-type="supplementary-material"}). Hence, 20 studies (1 of high quality and 19 of moderate quality) were included in this review. [Multimedia Appendix 5](#app5){ref-type="supplementary-material"} summarizes these 20 studies.

The PRISMA checklist of this study can be found in [Multimedia Appendix 6](#app6){ref-type="supplementary-material"}.

### Evidence: Clinical Effects

Of the 20 included studies, 19 reported clinical outcomes and only 1 study did not refer to any clinical effect \[[@ref55]\].

#### Glycated Hemoglobin

The main reported clinical outcome was glycated hemoglobin (HbA~1c~). Eighteen publications evaluated HbA~1c~ values and reported heterogeneous effects. On one hand, 4 publications reported significant improvements in HbA~1c~ values, favoring the groups that used social media comparison with control groups. This effect has been reported in 2 systematic reviews summarizing the evidence from studies focusing on both type one diabetes (T1D) and type two diabetes (T2D) and in 2 RCTs focusing specifically on T1D \[[@ref27],[@ref33],[@ref39],[@ref44]\]. In one of these systematic reviews two analyses were performed: one of them was a meta-analysis including RCTs only; in the second analysis, nonrandomized studies were also included. In the latter, a significant mean reduction in HbA~1c~ values was found, favoring the social media group (0.49%, 95% CI −0.64 to −0.34, I^2^=86%) \[[@ref39]\]. On the other hand, 13 RCTs reported significant improvements in HbA~1c~ values among all the study participants, independently of whether they were allocated to the group where social media was used or not. These studies mostly targeted young people affected with T1D \[[@ref26],[@ref28],[@ref30],[@ref32],[@ref34],[@ref35],[@ref45],[@ref54],[@ref60]\]. Furthermore, another study reported mixed results \[[@ref58]\]. The data analysis of all the participants included in this study (208 adults with T2D) did not show significant decreases in HbA~1c~ values. However, in a second analysis, it was found that patients with HbA~1c~≥10% at baseline had a significant decrease at 6 months \[[@ref58]\]. Two additional studies focusing on young people with T1D did not find any differences in HbA~1c~ values \[[@ref31],[@ref42]\].

#### Blood Pressure

Effects on blood pressure were reported only by 2 systematic reviews, both finding improvements associated with social media use. One of the systematic reviews referred to 5 studies with a total of 2580 patients (1317 in the intervention groups and 1263 in the control groups), where there was a significant mean difference in systolic blood pressure (3.47 mmHg, 95% CI 5.01 to 1.94, *P*\<.001, I^2^=0%) and diastolic blood pressure (1.84 mmHg, 95% CI 2.98 to 0.70, *P*=.002, I^2^=29%), favoring the intervention groups using social media \[[@ref39]\]. The second review also found reductions in blood pressure associated with Web 2.0 participation, reported in 2 studies \[[@ref33]\].

#### Other Reported Clinical Outcomes

Additional evidence on clinical effects has been reported for triglycerides and severe hypoglycemia episodes. Only 1 systematic review referred to the effect on triglycerides. This review reported the effect drawing on 10 studies with a total of 989 patients. A significant reduction of 11.05% (95% CI: 20.92 to 1.18, *P*=.03, I^2^=0) was found among the study participants where social media had been used \[[@ref39]\]. An RCT carrying out a 1-year intervention did not find any differences in severe hypoglycemia episodes for any of the study participants \[[@ref31]\].

### Evidence: Effects on Behavior

Of the 20 included studies, 16 referred to different effects on behavior.

#### Satisfaction With the Intervention

Five publications had comparable findings related to patients' high satisfaction with the interventions where social media were used or to internet visits being preferred by patients \[[@ref26],[@ref28],[@ref30],[@ref39],[@ref60]\].

#### Health-Related Quality of Life

Five studies reported on this item, reaching different conclusions. Two studies, an RCT and a systematic review, reported improvements in health-related quality of life (HRQoL) among T1D and T2D patients linked to social media use \[[@ref33],[@ref44]\]. Three RCTs with young T1D patients did not find any differences regarding HRQoL between the groups after the intervention \[[@ref27],[@ref31],[@ref48]\].

#### Diabetes Knowledge and Diabetes Empowerment

This effect was reported in 4 studies and with mixed conclusions. One study involving adolescents with T1D found significantly increased diabetes knowledge on treatment or testing in the intervention group at 4, 8, and 12 months \[[@ref42]\]. In another study on young people with T1D, it was found that social media use allowed patients to gain knowledge and information about diabetes and interact when making their daily insulin adjustments \[[@ref45]\]. On the other hand, 2 studies, both referring to a 1-year intervention carried out in Sweden with T1D patients, showed no improvement in diabetes empowerment \[[@ref27],[@ref31]\].

#### Medication Adherence

Two publications reported on treatment adherence. No differences were found regarding adherence in a systematic review \[[@ref33]\], while the social media intervention group of an RCT had significantly better medication adherence (*P*=.01) \[[@ref29]\].

#### Healthier Life-Styles

There were mixed results on this outcome as well. A systematic review described reductions in dietary fat intake, but the same review also found no effects on physical activity \[[@ref33]\]. However, a recently published RCT found a significant improvement in self-reported physical activity (est 0.28, *P*=.046) for those with the highest engagement in the site and a decreased sedentary time (Fitbit data) for the intervention group compared with that for a control group (est −12.17, *P*=.048) \[[@ref58]\].

#### Other Reported Behavioral Outcomes

Additional reported effects on behavior were an increase in diabetes communication (*P*\<.05) and medical self-efficacy (*P*\<.01) \[[@ref48]\], reductions in depressive symptoms \[[@ref33]\], and no significant differences in perceived quality of care \[[@ref31]\]. [Table 1](#table1){ref-type="table"} summarizes the evidence identified in this review on clinical and behavioral outcomes of interventions using social media and addressing people with diabetes.

### Targeted Population

Most (14/20) of the publications focused only on young people affected with T1D, with different age groups ranging from 0 to 23 years (as specified in the studies) \[[@ref26]-[@ref32],[@ref34],[@ref35],[@ref42],[@ref44],[@ref45],[@ref48],[@ref54]\]. Five publications referred to both T1D and T2D patients, and therefore, participants had a broader age range \[[@ref33],[@ref39],[@ref40],[@ref55],[@ref60]\]. Only one study specifically targeted adults diagnosed with T2D \[[@ref58]\]. The included primary studies were performed in Macedonia \[[@ref26],[@ref28],[@ref30],[@ref32],[@ref34],[@ref35],[@ref44],[@ref45],[@ref54]\], Sweden \[[@ref27],[@ref31]\], the United States \[[@ref48],[@ref55]\], and Ireland \[[@ref42]\], and the location was unspecified in 3 of the publications \[[@ref29],[@ref40],[@ref58]\].

### Social Media Use

The main use of social media was as a supporting tool for the main intervention (14/20), primarily used for reinforcing regular visits and with the purpose of engaging patients in treatment and improving self-management and diabetes control. In these cases, the chosen social media channels were Facebook (group), Facebook (chat), Skype, specific social networking sites, or social media in general \[[@ref26]-[@ref28],[@ref30]-[@ref32],[@ref34],[@ref35],[@ref40],[@ref44],[@ref45],[@ref48],[@ref55],[@ref58]\]. Of these studies, 7 (all of them belonging to the same research group) reported improvements in HbA~1c~ values for all study participants \[[@ref26],[@ref28],[@ref30],[@ref32],[@ref34],[@ref35],[@ref45]\]. Two studies found improvements in HbA~1c~ values only in the participants allocated to the social media groups \[[@ref27],[@ref44]\]. Two studies did not find any differences in HbA~1c~ values when social media was used as a supporting tool \[[@ref31],[@ref48]\]. Moreover, one study found mixed results, with no improvements in HbA~1c~ values for the whole sample but improvements for the participants in whom the values were higher at baseline \[[@ref58]\]. Two publications did not report on HbA~1c~ values linked to the use of social media as a supporting tool \[[@ref40],[@ref55]\].

###### 

Summary of the evidence on reported outcomes (n=20).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcomes                  Supported by number of publications                                                                                                                                                                       
  ------------------------- ------------------------------------- ------------------------------------------------------------------------------------------------------ ---------------- ------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------
  **Clinical effects**                                                                                                                                                                                                                

  \                         HbA~1c~^b^                            13^a^ \[[@ref26]-[@ref28],[@ref30],[@ref32]-[@ref35],[@ref39],[@ref44], [@ref45],[@ref54],[@ref60]\]   1 \[[@ref58]\]   4 \[[@ref29],[@ref31],[@ref42],[@ref48]\]   2 \[[@ref40],[@ref55]\]

  \                         Blood pressure                        2 \[[@ref33],[@ref39]\]                                                                                0                0                                           18 \[[@ref26]-[@ref32],[@ref34],[@ref35],[@ref40],[@ref42],[@ref44],[@ref45],[@ref48], [@ref54],[@ref55],[@ref58],[@ref60]\]

  \                         Triglycerides                         1 \[[@ref39]\]                                                                                         0                0                                           19 \[[@ref26]-[@ref35],[@ref40],[@ref42],[@ref44],[@ref45],[@ref48], [@ref54],[@ref55],[@ref58],[@ref60]\]

  \                         Severe hypoglycemia                   0                                                                                                      0                1 \[[@ref31]\]                              19 \[[@ref26]-[@ref30],[@ref32]-[@ref35],[@ref39],[@ref40],[@ref42],[@ref44],[@ref45],[@ref48], [@ref54],[@ref55],[@ref58],[@ref60]\]

  **Effects on behavior**                                                                                                                                                                                                             

  \                         HRQoL^c^                              2 \[[@ref33],[@ref44]\]                                                                                0                3 \[[@ref27],[@ref31],[@ref48]\]            15 \[[@ref26],[@ref28]-[@ref30],[@ref32],[@ref34],[@ref35],[@ref39],[@ref40],[@ref42],[@ref44], [@ref54],[@ref55],[@ref58],[@ref60]\]

  \                         Knowledge or empowerment              2 \[[@ref42],[@ref45]\]                                                                                0                2 \[[@ref27],[@ref31]\]                     16 \[[@ref26],[@ref28]-[@ref30],[@ref32]-[@ref35],[@ref39],[@ref40],[@ref44],[@ref48],[@ref54], [@ref55],[@ref58],[@ref60]\]

  \                         Medication adherence                  1 \[[@ref29]\]                                                                                         0                1 \[[@ref33]\]                              18 \[[@ref26]-[@ref28],[@ref30]-[@ref32],[@ref34],[@ref35],[@ref39],[@ref40],[@ref42],[@ref44], [@ref45],[@ref48],[@ref54],[@ref55],[@ref58],[@ref60]\]

  \                         Healthier self-reported life-styles   1 \[[@ref58]\]                                                                                         1 \[[@ref33]\]   0                                           18 \[[@ref26]-[@ref32],[@ref34],[@ref35],[@ref39],[@ref40],[@ref42],[@ref44],[@ref45],[@ref48], [@ref54],[@ref55],[@ref60]\]

  \                         Self-efficacy                         1 \[[@ref40]\]                                                                                         1 \[[@ref48]\]   0                                           18 \[[@ref26]-[@ref35],[@ref39],[@ref42],[@ref44],[@ref45],[@ref54], [@ref55],[@ref58],[@ref60]\]

  \                         Depressive symptoms                   1 \[[@ref33]\]                                                                                         0                0                                           19 \[[@ref26]-[@ref32],[@ref34],[@ref35],[@ref39],[@ref40],[@ref42],[@ref44],[@ref45], [@ref48],[@ref54],[@ref55],[@ref58],[@ref60]\]

  \                         Perceived quality of care             0                                                                                                      0                1 \[[@ref31]\]                              19 \[[@ref26]-[@ref30],[@ref32]-[@ref35],[@ref39],[@ref40],[@ref42],[@ref44],[@ref45],[@ref48], [@ref54],[@ref55],[@ref58],[@ref60]\]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^13 studies reported improvements in HbA~1c~ values in all study participants; 4 of these studies reported improvements only in the intervention groups (comparison with control groups) \[[@ref27],[@ref33],[@ref39],[@ref44]\].

^b^HbA~1c~: Glycated hemoglobin.

^c^HRQoL: health-related quality of life.

Three RCTs studied social media as the main channel for delivering the intervention. These 3 studies used peers in educational and behavioral interventions aimed at young people affected with T1D. The purpose of these interventions was to increase diabetes knowledge and to improve clinical outcomes. These 3 studies used Facebook closed groups and Viber \[[@ref29],[@ref42],[@ref54]\]. Two of them did not find any significant differences in HbA~1c~ values \[[@ref29],[@ref42]\], while the third study reported improvements in HbA~1c~ values among all the participants \[[@ref54]\]. The use of social media as a main channel for delivering the intervention or as a supporting tool was not clearly stated in any of the 3 systematic reviews \[[@ref33],[@ref39],[@ref60]\].

Discussion
==========

Summary of the Evidence
-----------------------

A rapid review method was used to quickly capture the current evidence on the use of social media in interventions on diabetes. Following a search in 4 databases, only 20 publications considered of adequate quality were included in this review: 3 systematic reviews and 17 primary studies.

The research evidence shows that the most commonly reported outcome in intervention studies using social media is HbA~1c~, followed by satisfaction with the intervention, HRQoL, and diabetes knowledge or empowerment. Most of the intervention studies using social media that evaluated HbA~1c~ values reported significant improvements (13/16 publications) \[[@ref26]-[@ref28],[@ref30],[@ref32]-[@ref35],[@ref39],[@ref44],[@ref45],[@ref54],[@ref60]\]. Four of these publications, 2 systematic reviews and 2 RCTs, reported improvements only in intervention groups compared with that in control groups \[[@ref27],[@ref33],[@ref39],[@ref44]\]. However, due to a heterogeneity in the methods that were used in the studies, including differences in the characteristics of participants, sample sizes, and study lengths, comparing them is difficult.

The 5 studies that measured satisfaction with the interventions where social media were used unanimously reported positive effects \[[@ref26],[@ref28],[@ref30],[@ref39],[@ref60]\]. Two publications reported positive effects on HRQoL \[[@ref33],[@ref44]\], and 2 others found improvements in knowledge \[[@ref42],[@ref45]\], while 3 publications did not report any significant differences in HRQoL \[[@ref27],[@ref31],[@ref48]\] or any improvements in knowledge \[[@ref27],[@ref31]\].

Should We Use Social Media in Interventions for People With Diabetes?
---------------------------------------------------------------------

Health authorities have recommended educating diabetic patients and their families with the aim of improving self-management, promoting a positive behavior change, and reducing the risk of complications \[[@ref1]-[@ref7]\]. Although the use of social media has not been linked to clear improvements in one meta-analysis focusing on patients with noncommunicable diseases \[[@ref14]\], there are several other meta-analyses where some favorable effects have been found among people affected with chronic diseases \[[@ref10]-[@ref13],[@ref39]\]. The findings of the present review suggest that the use of social media in interventions for diabetes in many cases has been beneficial, and we did not find any studies that suggested worsened outcomes with this type of intervention. Studies using social media in their interventions have mostly showed superior results linked to the use of social media. Only one of the publications included in this review did not report any benefit on clinical or behavioral outcomes \[[@ref30]\]. In this case, the researchers used social media in a 1-year intervention, and they used their own social media channel \[[@ref31]\].

It is interesting to note that more than half of the studies used social media as a tool or resource to enhance the main intervention, and in these cases, the interventions resulted in improvements in HbA~1c~ values. Participants in these studies who were allocated to receive education either through Facebook chat or Skype as reinforcement of the main intervention had significant decreases in HbA~1c~ values \[[@ref26],[@ref28],[@ref30],[@ref32],[@ref34],[@ref35],[@ref45]\]. Furthermore, compared with patients in the control group, improvements in HbA~1c~ levels were found among patients receiving health education through closed groups on Facebook and were found in one study using its own social media network \[[@ref27],[@ref44]\]. In only 2 studies where social media was used as a supporting tool no differences in HbA~1c~ values were found; these 2 studies used their own social media channel \[[@ref31],[@ref48]\].On the other hand, only 1 of the 3 studies that used social media as a main channel for delivering the intervention and measured HbA~1c~ values \[[@ref29],[@ref42],[@ref54]\] reported significant improvements. This study used Viber communication for delivering doctor or peer support \[[@ref54]\].

These findings suggest that using social media as a supporting tool for the main intervention is beneficial for improving health outcomes in T1D patients. Furthermore, it seems that the clinical improvement is most likely to happen when the chosen social media is one of the most popular networking sites.

Our review has mainly identified studies conducted with young T1D populations; however, our conclusions are comparable to those reported in a meta-analysis published in 2014 that predominantly analyzed studies involving T2D patients \[[@ref39]\]. Therefore, we think that public health institutions, clinicians, and other stakeholders should consider the use of social media in their interventions targeting people affected with diabetes. However, special attention should be paid to the risk of misinformation or harmful health material that can coexist when carrying out interventions in open social media channels as it could lead to undesirable or unexpected effects \[[@ref62]-[@ref67]\].

Knowledge Gaps and Next Directions
----------------------------------

Most of the included studies focused only on young people affected with T1D, probably because it is believed that these media are typically used by young people. Certainly, since the origin of social media, younger people have been the most frequent users of these channels. However, the presence of older generations on social media has increased in recent years, and about 80% of North Americans and Norwegians in their 40s report being social media users \[[@ref8],[@ref68]\]. Hence, including older populations through social media would also make sense. This could be an especially valuable way of targeting people affected with T2D, a disease that is mostly diagnosed in adulthood and whose prevalence has dramatically increased in the last few decades \[[@ref1]\]. Intervention studies using social media seem to improve health outcomes in T1D patients, and they could be beneficial for people with T2D as well. However, more research, using social media, on diabetes types is needed to answer this question.

In this review, we identified many abstracts presented at conferences, but there were fewer full papers reporting methods and results in detail. Knowing further details of the method used and the interventions could help identify the mechanisms or behavior techniques that work better for improving patient outcomes. So far, it seems that studies that use social media as supporting tool and where the social media is used for delivering health education report better outcomes. However, there are not enough studies where social media was used as the main channel for delivering the intervention. In future research, one should consider using different social media channels as main sources for delivering the intervention.

In research projects, it is more common to use restricted-access social media (ie, Facebook closed groups, Facebook chat, Skype, etc), which allows the researcher to have a better control of the environment and the contents and also protect the patients' privacy. However, the use of open social media channels offers the possibility of a large-scale impact. Providing high-quality contents on diabetes through the most commonly used open social media channels and interacting with the social media users could potentially help people with diabetes. By having access to free-of-charge quality information, they could improve their knowledge, an important prerequisite for improving self-management and health behaviors. Further research should explore how to best use open social media channels for health promotion interventions in diabetes.

Strengths and Limitations
-------------------------

Our results and conclusions might be susceptible to bias as a consequence of streamlining the systematic review process. There might be a selection bias (failure to search in additional potentially relevant databases, only 1 reviewer selecting the studies) and a publication bias (we only searched in 4 databases; we did not search for gray literature; and our search was limited to the English language). Eight of the included studies conducted in Macedonia could be based on the same study, although we treated the reported results independently, as they provided different sample sizes, different age ranges of the included participants, and different intervention periods. Because many of the included publications were abstracts presented at conferences and because we did not have access to complete data, a quantitative synthesis was not possible.

Conclusion
----------

There is little evidence on the use of social media in interventions aimed at people affected with diabetes. However, after weighing the existing evidence, it seems that the use of these channels is predominantly linked to beneficial patient outcomes. Public health institutions, clinicians, and other stakeholders who aim at improving diabetes patient education should consider the use of social media in their interventions.
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HbA~1c~
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HRQoL
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RCT

:   randomized controlled trial

T1D

:   type 1 diabetes

T2D
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